Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. - Wikidata - wikimedia - TriplyDB

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

http://www.wikidata.org/entity/Q34650742

about

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies Update on the Diagnosis and Treatment of Cholangiocarcinoma.Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access.Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy.Intrahepatic cholangiocarcinoma: current perspectives.Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.Intraarterial therapies for primary liver cancer: state of the art.(90)Y-glass microspheres for hepatic neoplasia.Transarterial approaches to primary and secondary hepatic malignancies.Multimodality treatment of intrahepatic cholangiocarcinoma: A review.Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.Locoregional Therapies of Cholangiocarcinoma.Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study.Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization.Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE.Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma.Evaluation of Liver Stiffness After Radioembolization by Real-Time ShearWave™ Elastography: Preliminary Study.Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.Radioembolization as a Treatment Option.Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives In Reply Current state of nonsurgical therapies for cholangiocarcinoma

P2860

Q26741882-583A4073-36E8-492D-8CB5-A550FB11D686 Q26781036-71C3686C-BFE4-41F9-965F-74D269D05F23 Q26799046-7F06211B-F8BC-46ED-A4F5-83ABA8A9D811 Q28071594-E87FFD0D-45D5-4AD5-9F92-9B4046F029AB Q30238895-63EEED18-878D-4A34-8B8B-6A1C578C0F1C Q33621522-806EA92F-FAF6-40C3-9027-B7B81F68F293 Q33844564-F7A03BA5-6C89-45FE-A28D-246A46855BBF Q34484245-F1467178-C597-40E0-972F-F8E27B21726F Q35046078-F31D18EB-E2BC-49E6-9BD0-0A0295D43EA4 Q35656582-BC522A71-F433-4250-84A7-4C402FF6F896 Q37151082-56862846-041F-4894-BED1-6BE129AC8F87 Q37249793-400D29CB-89C2-4ACD-9A53-567743582D39 Q37525291-91EB21C8-1D5F-4DA1-9DF7-7585CECE403F Q37582417-3E9C8CD4-38EB-47EC-A726-7D794BFFC3D2 Q37669928-7A181F03-B249-405F-8A6B-0B90F743B5A3 Q37675072-971B9900-3FDD-4A75-A0BD-1A197F39979E Q38149993-AF3D82B7-8E97-442B-9EA7-53BAC8DBEF4B Q38465831-9BCCD2E8-9CA5-4221-93E9-3F7C35FA324C Q38488732-EA16DFD2-68A7-41B2-9E12-383654C9A1E3 Q38707365-786A95E0-BDB9-46E8-9276-23A6242F86E0 Q38739690-A6E48C3F-6F5E-41CB-9E3D-6B776377B0F6 Q38778958-2AFB182D-89EC-4F41-8269-10CAF045E872 Q38947234-32A719E2-AFF1-4C30-AF15-21F06999F3C0 Q38972508-945ADF4C-CAE3-4FCE-B2F1-7BFCFF68371E Q39048862-78AECE25-8C5E-4AFA-AA4B-032949939025 Q39206964-7BEC0D9D-EF49-4CA9-B024-9BB25FE7AD52 Q39349626-E5552EFF-D8FF-4A1D-BA06-96DD2CC063B8 Q40235400-A5A93018-2108-4F55-9670-1A354888A7AD Q41654192-8D66DF2D-3418-482C-AC0C-17211087C183 Q41951208-E303032A-9777-49A5-8456-9C533099AB87 Q42342892-BA91018B-7206-4B22-B3C4-A77D9893C9FC Q42773491-15C1BB3C-5BF0-41F6-B6B0-5AB227897C66 Q45168728-D9F97683-9A3D-403C-839E-2B1102DD53AE Q45207818-F814C9A3-5B78-47DA-B532-B55FA63A1EFC Q47137682-CE48F2ED-18F8-4A3E-9CD1-DD09F955D56F Q49627939-325A0152-004D-4132-8298-4F2B3A5BA59C Q51719965-8D570B67-2546-4507-8735-82BBA26D0241 Q57139983-A0BA359C-0628-43AA-9F9E-E11DE1D9BB15 Q57144927-E7A312EF-BD97-4EB8-8B9D-AEBEE83EEA67 Q57154668-42162FD3-1B80-4424-8400-B90BDC11A7AC

P2860

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

http://www.wikidata.org/entity/Q34650742

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@ast

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@en

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@nl

type

label

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@ast

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@en

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@nl

prefLabel

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@ast

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@en

Yttrium-90 radioembolization f ...... sponse, and survival analysis.

@nl

P1433

Q34650742-2734A333-72C4-4678-83A9-AB3C0590ADCF

P1476

Q34650742-034C1430-2341-471F-B1B7-9560FDACFC61

P2093

Q34650742-3306471E-F01A-45C2-B1A5-8A0F59E6B055

Q34650742-5AD2944D-A0D7-42CE-866E-3F71569DDFA7

Q34650742-7D8079F0-D0DB-40CC-B665-E3B4DABC6A95

Q34650742-A1A78DEE-503A-4863-A0AC-3E570AF0A87B

Q34650742-CA1D7459-E6B1-4387-9A20-B1C5E7C57BA7

Q34650742-DE682FE8-385D-42B2-A8A1-F9088EE90793

Q34650742-DFF2D53A-783A-4DA1-87A1-E76237359B05

Q34650742-F9081ECF-AAA3-47D8-88B8-D20A158C8C13

P2860

Q34650742-06610829-6DC2-49FB-95C9-7CDE4312B7FD

Q34650742-0F68F556-26D9-45F7-9013-7C149367E1DA

Q34650742-1517F84E-1C5A-4146-8581-D441AB81E17D

Q34650742-160110B9-ADEB-47F6-92E9-564950336339

Q34650742-25DE605A-E470-4CE1-AFF5-832716389033

Q34650742-2A1F828E-6516-4FF8-83AF-BE3DA3BD9182

Q34650742-2F3AB8CD-2A7E-4FB1-9338-90D33D70571E

Q34650742-3795A121-CE2A-4B2C-B2FD-26091B8EB30E

Q34650742-519657C4-7C50-4270-BC2F-719F5B9CF671

Q34650742-5929D325-F03C-4EEC-BB94-1E8C51364D85

P304

Q34650742-4EEFAF78-7BFB-490B-8636-FF4D15B12DC8

P31

Q34650742-2E580252-ECF3-47C4-9159-005BADB5FC49

P356

Q34650742-1B31764C-7C30-4EE3-9744-092B87A4C8A1

P433

Q34650742-882C2442-4692-4500-A82B-F14FEA4030C4

P478

Q34650742-D9BF21F0-F353-456F-973B-0364075ABD04

P50

Q34650742-EAD0EB83-7855-414B-9256-38808CAB9240

P577

Q34650742-0AD2121E-4B67-4584-A9D6-82126DA8B50A

P698

Q34650742-1D3539D1-17EA-4A07-B890-E2EF49D00E2C

P921

Q34650742-1AEEC1BD-C052-43FD-8CA5-1069CCABA945

P932

Q34650742-4AD3824F-BBF8-4E7E-844E-DEF06EA6DB28

P356

J.JVIR.2013.02.031

P1433

Journal of Vascular and Interventional Radiology

P1476

Yttrium-90 radioembolization f ...... esponse, and survival analysis

@en

P2093

Al B Benson

http://www.w3.org/2001/XMLSchema#string

Khairuddin Memon

http://www.w3.org/2001/XMLSchema#string

Mary F Mulcahy

http://www.w3.org/2001/XMLSchema#string

Ramona Gupta

http://www.w3.org/2001/XMLSchema#string

Robert J Lewandowski

http://www.w3.org/2001/XMLSchema#string

Robert K Ryu

http://www.w3.org/2001/XMLSchema#string

Samdeep Mouli

http://www.w3.org/2001/XMLSchema#string

Talia Baker

http://www.w3.org/2001/XMLSchema#string

P2860

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Role of radiation after operative palliation in cancer of the proximal bile ducts.

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.

Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.

Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.

P304

1227-1234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVIR.2013.02.031

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23602420

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3800023

http://www.w3.org/2001/XMLSchema#string